Citations

Institution: Mayo Clinic Clear

Showing 10 of 108135 citations.

Turkey Versus Guinea Pig Red Blood Cells: Hemagglutination Differences Alter Hemagglutination Inhibition Responses Against Influenza A/H1N1
Ovsyannikova, Inna G. , White, Sarah J., Albrecht, Randy A. , García‐Sastre, Adolfo , Poland, Gregory A. , García-Sastre, Adolfo

Viral Immunology | April 30, 2014 | Volume: 27 | Issue: 4 | Pages: 174-178

10.1089/vim.2013.0111 | PMID 24787023 Get It

For influenza hemagglutination inhibition (HAI) assays, species selection of red blood cells (RBCs) is critical to determine antibody titers to influenza viruses reliably. We compared pandemic influenza virus A/H1N1 (pdH1N1) HAI titers using turkey or guinea pig RBCs. Turkey RBCs appear to be the more appropriate species choice for influenza A/pH1N1 HAI assays.
Toll-Like Receptors: Novel Molecular Targets for Antiviral Immunotherapy
Eid, Albert, Hénault, Martin, Razonable, Raymund R.

Antiviral Research | April 30, 2014 | Volume: No volume available | Issue: No issue available | Pages: 333-346

10.1128/9781555815493.ch19 Get It

Prosthetic Joint Infections
Steckelberg, James M., Osmon, Douglas R.

Infections Associated with Indwelling Medical Devices | April 30, 2014 | Volume: No volume available | Issue: No issue available | Pages: 173-209

10.1128/9781555818067.ch9 Get It

Probing Antibody-Antigen Interactions
Yang, Guocheng, Velgos, Stefanie N., Boddapati, Shanta , Velgos, Stefanie N., Sierks, Michael R.

Microbiology Spectrum | April 30, 2014 | Volume: 2 | Issue: 1 | Pages: No page available

10.1128/microbiolspec.aid-0010-2013 | PMID 26082105 Get It

ABSTRACT Antibodies are biological molecules generated by the host immune system in response to the invasion of foreign bodies or antigens. Therefore, antibodies must possess high specificity toward target antigens in order for the antigen to be recognized and subsequently destroyed. Because of this specificity, antibodies or antibody fragments that maintain binding specificity are heavily used in diagnostic assays and are becoming increasingly important in many therapeutic applications. Classical immunoassays such as radioimmunoassay and enzyme-linked immunosorbent assay are effective analytical techniques that have been widely used to screen and determine antibody specificity. Because of increased demands for antibodies with well-defined specificities, other techniques have been developed that facilitate generation and characterization of antibody-binding specificities under different conditions, such as when the protein is expressed on a cell surface or the target antigen is hard to isolate. Here, we describe three alternate techniques that provide unique abilities to characterize antibody-antigen binding events: (i) surface plasmon resonance, (ii) fluorescence activated cell sorting, and (iii) atomic force microscopy. These different techniques take advantage of various changes in physical and/or chemical properties of the analytes that occur upon binding, such as refractive index, surface charge, and changes in structure. These techniques provide unique powerful advantages over traditional immunoassays including real-time and label-free detection, low sample volume and concentration requirements, and molecular-level detection sensitivity. This article provides an overview of how these alternate approaches to studying antibody-antigen interactions can be used to facilitate rapid development of new antibody-based reagents for diagnostic and therapeutic applications.
Radiation reduction in pediatric and adult congenital patients during cardiac catheterization
Mauriello, Daniel, Fetterly, Kenneth A. , Lennon, Ryan J. , Reeder, Guy S., Taggart, Nathaniel W. , Hagler, Donald J. , Cetta, Frank , Mauriello, Daniel A, Cabalka, Allison K. , Taggart, Nathaniel W

Catheterization and Cardiovascular Interventions | April 30, 2014 | Volume: 84 | Issue: 5 | Pages: 801-808

10.1002/ccd.25533 | PMID 24782364 Get It

ObjectivesOur objective was to determine if technical changes combined with radiation safety initiatives reduced the radiation dose delivered to patients during congenital catheterization.BackgroundUse of ionizing radiation is necessary during cardiac catheterization. Minimizing radiation dose, while maintaining clinically useful image quality, is an important safety issue. In our congenital heart center intentional practice changes, including technical changes and provider awareness initiatives, were implemented to decrease radiation dose.MethodsData were retrospectively collected for all procedures involving children and adults with congenital heart disease (CHD) undergoing catheterization over 45 months. Cases were divided into three categories including: noninterventional (NI), simple intervention (SI), and complex intervention (CI). The change in dose was modeled as log of cumulative air kerma (Ka,r). The change in Ka,r was evaluated for each procedural category as well as changes occurring as a function of age and weight.ResultsConsidering all procedures (n = 1,082), Ka,r decreased by 61%. In the NI group (n = 481), Ka,r decreased by 71%. In the SI group (n = 424), Ka,r decreased by 74%. The Ka,r for the 10–17 year old group (n = 125) and those ≥18 years (n = 709) decreased 74 and 67%, respectively. The Ka,r decreased 72 and 66% for those 20–60 kg and ≥60 kg, respectively. Groups not showing significant change in Ka,r included CI, age ≤9 years, and weight ≤20 kg.ConclusionsThrough technical changes and provider awareness initiatives, our institution dramatically reduced the radiation dose in the majority of pediatric and adult CHD patients undergoing cardiac catheterization. © 2014 Wiley Periodicals, Inc.
Distinct roles of age and abdominal visceral fat in reducing androgen receptor‐dependent negative feedback on LH secretion in healthy men
Takahashi, Paul Y. , Liu, P. Y., Veldhuis, J. D., Takahashi, Paul

Andrology | April 30, 2014 | Volume: 2 | Issue: 4 | Pages: 588-595

10.1111/j.2047-2927.2014.00218.x | PMID 24782426 Get It

SummaryTestosterone (T) impacts luteinizing hormone (LH) secretion through negative feedback via the androgen receptor (AR) in the hypothalamo‐pituitary system. An untested postulate is that increasing body mass index (BMI), abdominal visceral fat (AVF) or total abdominal fat (TAF) with ageing decreases LH secretion by heightening T negative feedback via AR. This hypothesis was tested in a prospective, randomized double‐blind cross‐over study of 19 healthy men comparing the effects of flutamide, a selective non‐steroidal AR antagonist and placebo administration on basal and pulsatile LH secretion as a function of age and obesity measures. To this end, serum levels of 2‐hydroxyflutamide (2‐OHF), a major active flutamide metabolite, were measured by mass spectrometry, and AVF/TAF quantified by abdominal computerized tomography. Statistical analysis showed that antiandrogen administration elevated 6‐h mean LH concentrations to 5.4 ± 1.3 IU/L compared with 3.3 ± 1.2 IU/L for placebo (p < 10−3), and total T by 35% (p < 10−4). The LH‐T concentration product doubled (p < 10−8). According to deconvolution analysis, flutamide exposure increased total LH secretion (p < 10−3) and pulsatile LH secretion (p = 0.0077), along with LH pulse frequency (p = 0.019). Despite feedback inhibition, the LH‐T product declined as a linear function of AVF (p = 0.021) and TAF (p = 0.017). This was explained by the fact that higher BMI was associated with lower 2‐OHF concentrations (R = −0.562, p = 0.012). In contrast, age was associated with less pulsatile LH secretion (R = −0.567, p = 0.011) even when LH responses were normalized to antiantrogen levels. In conclusion, increased AVF, TAF and BMI predict decreased LH and flutamide blood levels, whereas older age is marked by impaired stimulation of pulsatile LH secretion even when normalized for antiandrogen levels, suggesting different mechanisms of regulation by adiposity and age.
Detection rate and outcome of colonic serrated epithelial changes in patients with ulcerative colitis or Crohn's colitis
Johnson, David H. , Khanna, Sahil , Smyrk, Thomas C. , Loftus, Edward V. , Anderson, Kari, Ahlquist, David A. , Mahoney, Douglas W. , Kisiel, John B. , Loftus, Edward V

Alimentary Pharmacology & Therapeutics | April 30, 2014 | Volume: 39 | Issue: 12 | Pages: 1408-1417

10.1111/apt.12774 | PMID 24779703 Get It

SummaryBackgroundChronic ulcerative colitis (CUC) and colonic Crohn's disease (CD) increase colorectal neoplasia (CRN) risk. While sessile serrated polyp (SSP) is a known cancer precursor, serrated epithelial changes (SEC) are of uncertain prevalence and neoplastic risk.AimTo assess the serrated lesion detection rates in CUC and CD and documented incidence of subsequent CRN in a retrospective, single‐centre cohort study.MethodsPatients were identified by a central diagnostic index and pathology review confirmed SEC, SSP, CUC and CD diagnoses from 2006–12. Matched controls were identified from among all CUC and CD patients having colonoscopy during the second half of the time period. All were followed for incident CRN, estimated by the Kaplan–Meier method.ResultsBetween 2006 and 2012, 79 SEC and 10 SSP cases were identified. Detection rates were estimated to be 10/1000 and 2/1000 patients, for SEC and SSP respectively, among 4208 unique CUC or CD patients having colonoscopy from 2010–12. With only 10 cases, SSP patients were not further analysed. Cumulative incidence of subsequent CRN at 1 and 3 years was 12% (95% CI, 0–30%) and 30% (3–57%), respectively, in SEC patients compared to 4% (0–12%) and 9% (0–23%), respectively, in CUC or CD controls (P = 0.047, log‐rank). However, this statistical difference was not significant after patients were stratified for history of prior or synchronous dysplasia (P = 0.09).ConclusionsSerrated epithelial changes and sessile serrated polyps are uncommonly detected by colonoscopy in chronic ulcerative colitis and Crohn's disease patients. Histology with changes of serrated epithelium may be associated with risk of subsequent colorectal neoplasia, however further studies are needed to explore this relationship.
Insulin‐like growth factor‐1 regulates the SIRT 1‐p53 pathway in cellular senescence
Tran, Duc T. , Zhang, Haibo , He, Hanbing, Wang, Yang , Li, Qintong , Kirkland, James L. , Bergholz, Johann S. , Zhang, Yujun , Xiao, Zhi‐Xiong Jim

Aging Cell | April 30, 2014 | Volume: 13 | Issue: 4 | Pages: 669-678

10.1111/acel.12219 | PMID 25070626 Get It

Summary Cellular senescence, which is known to halt proliferation of aged and stressed cells, plays a key role against cancer development and is also closely associated with organismal aging. While increased insulin‐like growth factor ( IGF ) signaling induces cell proliferation, survival and cancer progression, disrupted IGF signaling is known to enhance longevity concomitantly with delay in aging processes. The molecular mechanisms involved in the regulation of aging by IGF signaling and whether IGF regulates cellular senescence are still poorly understood. In this study, we demonstrate that IGF ‐1 exerts a dual function in promoting cell proliferation as well as cellular senescence. While acute IGF ‐1 exposure promotes cell proliferation and is opposed by p53, prolonged IGF ‐1 treatment induces premature cellular senescence in a p53‐dependent manner. We show that prolonged IGF ‐1 treatment inhibits SIRT 1 deacetylase activity, resulting in increased p53 acetylation as well as p53 stabilization and activation, thus leading to premature cellular senescence. In addition, either expression of SIRT 1 or inhibition of p53 prevented IGF ‐1‐induced premature cellular senescence. Together, these findings suggest that p53 acts as a molecular switch in monitoring IGF ‐1‐induced proliferation and premature senescence, and suggest a possible molecular connection involving IGF ‐1‐ SIRT 1‐p53 signaling in cellular senescence and aging.
CD28-mediated pro-survival signaling induces chemotherapeutic resistance in multiple myeloma
Murray, Megan , Gavile, Catherine M., Koorella, Chandana, Carlson, Louise, Buac, Daniela, Utley, Adam, Chesi, Marta , Bergsagel, P. Leif , Boise, Lawrence , Lee, Kelvin P. , Bergsagel, P. Leif , Lee, Kelvin P , Nair, Jayakumar R. , Boise, Lawrence H

Blood | April 30, 2014 | Volume: 123 | Issue: 24 | Pages: 3770-3779

10.1182/blood-2013-10-530964 | PMID 24782505 Get It

Key PointsCD28 delivers a pro-survival signal to MM cells via regulation of PI3K/Akt, FoxO3a, and Bim. Blockade of CD28:CD80/CD86 in vivo resensitizes MM cells to chemotherapy and significantly reduces tumor burden.
Age of Collagen in Intracranial Saccular Aneurysms
Etminan, Nima , Dreier, Rita , Buchholz, Bruce A. , Beseoglu, Kerim , Brückner, Peter , Matzenauer, Christian, Torner, James C., Brown, Robert D., Steiger, Hans-Jakob, Hänggi, Daniel , Macdonald, R. Loch , Torner, James C.

Stroke | April 30, 2014 | Volume: 45 | Issue: 6 | Pages: 1757-1763

10.1161/strokeaha.114.005461 | PMID 24781080 Get It

Background and Purpose— The chronological development and natural history of cerebral aneurysms (CAs) remain incompletely understood. We used 14 C birth dating of a main constituent of CAs, that is, collagen type I, as an indicator for biosynthesis and turnover of collagen in CAs in relation to human cerebral arteries to investigate this further. Methods— Forty-six ruptured and unruptured CA samples from 43 patients and 10 cadaveric human cerebral arteries were obtained. The age of collagen, extracted and purified from excised CAs, was estimated using 14 C birth dating and correlated with CA and patient characteristics, including the history of risk factors associated with atherosclerosis and potentially aneurysm growth and rupture. Results— Nearly all CA samples contained collagen type I, which was <5 years old, irrespective of patient age, aneurysm size, morphology, or rupture status. However, CAs from patients with a history of risk factors (smoking or hypertension) contained significantly younger collagen than CAs from patients with no risk factors (mean, 1.6±1.2 versus 3.9±3.3 years, respectively; P =0.012). CAs and cerebral arteries did not share a dominant structural protein, such as collagen type I, which would allow comparison of their collagen turnover. Conclusions— The abundant amount of relatively young collagen type I in CAs suggests that there is an ongoing collagen remodeling in aneurysms, which is significantly more rapid in patients with risk factors. These findings challenge the concept that CAs are present for decades and that they undergo only sporadic episodes of structural change.